摘要
目的:评价依迭拉奉治疗急性脑梗死的疗效和安全性。方法:2006年1月-2009年6月间选择本院患急性脑梗死患者80例,随机分为对照组和治疗组各40例,对照组常规应用抗血小板聚集、改善微循环和对症治疗,同时应用生理盐水和奥扎格雷进行治疗;治疗组在常规应用抗血小板聚集、改善微循环和对症治疗的基础上应用依迭拉奉30mg静脉滴注,2次/d,共用14d,评价两组的疗效。结果:治疗组的有效率明显高于对照组,两组间差异有统计学意义(P〈0.05)。结论:依这拉奉治疗急性脑梗死安全有效。
Objective: To evaluate the edaravone treatment of acute cerebral infarction, and security. Methods: In January 2005 -2009patients were enrolled in June between 80 patients with acute cerebral infarction were randomy divided into control group and treatment group 40 cases, group were treated with anti--p[atelet aggregation, microcirculation, and symptomatic treatment, by applying saline and treated Ozagrel; treatment group ap- plied in conventional anti--platelet aggregation, improve microcirculation and symptomatic treatment based on the application of intravenous infusion of edaravone 30mg, 2 times / d, share the 14d, were evaluated the efficacy. Results : The treatment group was significantly higher efficiency difference between two groups was statistically significant (P〈0.05). Conclusion: Edaravone safe and effective treatment of acute cerebral infarction.
关键词
依达拉奉
脑梗死
疗效
edaravone
cerebral infarction
effect